At a special event December 11, attended by trustees from Sanford Burnham Prebys and featuring brief talks by many of the Institute’s newest faculty, the inaugural Erkki Ruoslahti Award for Transformational Leadership was presented to T. Denny Sanford.
The new award honors recipients whose visionary leadership drives positive change, inspires groundbreaking solutions and contributes to the transformation of industries and society.
It is named after one of the institute’s earliest faculty and its president from 1989 to 2002. Ruoslahti made seminal contributions to the discovery of cell adhesion receptors known as integrins, helped developed a novel class of tumor-homing peptides and advanced the science of nanomedicine.
His past honors include elected membership to the U.S. National Academy of Sciences, National Academy of Medicine, American Academy of Arts and Sciences, and the European Molecular Biology Organization, the Japan Prize, Gairdner Foundation International Award, G.H.A. Clowes Award, Robert J. and Claire Pasarow Foundation Award and Jacobaeus International Prize.
In 2022, Ruoslahti was announced as one of three winners of the Albert Lasker Basic Medical Research Award, sometimes called “America’s Nobel.”
Sanford is, of course, one of the institute’s three namesakes, a distinguished businessman and philanthropist who has long supported its work and vision.
“Denny Sanford has been a friend, supporter and mentor for many, many years. He believes in the importance and value of both basic and translational science, of helping patients and the world become better and healthier,” said Brenner.
“His past, present and future support of Sanford Burnham Prebys is critical to our vision and mission. No one has done more. This award is a heart-felt, tangible symbol of our gratitude.”
Watch Award Presentation
Institute News
A Conversation About Aging and Cancer at Sanford Burnham Prebys
Event recording now available for panel discussion with scientists held on October 9, 2024
David A. Brenner, MD, president and CEO of Sanford Burnham Prebys, welcomed attendees to the launch of a new community engagement program called “A Conversation About” in the institute’s Victor E. LaFave III Memorial Auditorium on October 9, 2024.
The initial panel discussion in the A Conversation About series focused on the connection between aging and cancer and included information about a current breast cancer research collaboration. A recording of the event is available online.
Reena Horowitz, the founder of Group of 12 and Friends at Sanford Burnham Prebys, provided introductory remarks. Brooke Emerling, PhD, director of the Cancer Metabolism and Microenvironment Program, moderated the discussion among three featured panelists:
Peter Adams, PhD, director of the Cancer Genome and Epigenetics Program, Sanford Burnham Prebys
Xiao Tian, PhD, assistant professor in the Degenerative Diseases Program, Sanford Burnham Prebys
Kay Yeung, MD, PhD, associate clinical professor in the Division of Hematology-Oncology, University of California San Diego Health
By bringing together community collaborators and clinicians with Sanford Burnham Prebys researchers, A Conversation About offers a unique perspective on how clinical research and practice can be used to inform fundamental and translational science.
Watch Event Recording
Institute News
Ceremony celebrates recipients of 2024 Fishman Fund awards honoring exceptional postdoctoral scholars
2024 Fishman Award winners. From left: Huijie Huang, Kelly Yichen Li, Chiara Nicoletti, James Marchant, Jessica Proulx, Zinia D’Souza
Six young scientists at Sanford Burnham Prebys, whose research spans genetic disorders, Alzheimer’s disease, heart failure and aging, were honored September 17 at the 23rd annual Fishman Fund awards ceremony.
The Fishman Fund was created in 2001 by Sanford Burnham Prebys supporters Mary Bradley and Reena Horowitz to honor Dr. William and Mrs. Lillian Fishman, who founded the institute in 1976. In 2010, Jeanne Jones became a co-founder designee.
The awards are intended to support and promote early career scientists at Sanford Burnham Prebys. Four career development awards provide $10,000 stipends that can be used to attend workshops, network and travel to national and international conferences to learn about the latest developments in their research fields. In addition, the prizes include a two-year fellowship award, and an honor focused on rewarding research excellence. The fund is made possible through the generosity of many donors.
The ceremony, which included poster presentations, was held at the Sanford Consortium for Regenerative Medicine. The 2024 recipients are:
Reena Horowitz and Mary Bradley Fishman Fund Award
Zinia D’Souza, PhD, is a postdoctoral associate in the laboratory of Hudson Freeze, PhD, director of the Sanford Children’s Health Research Center and the director of the Human Genetics Program.Her research is focused on identifying new congenital disorders of glycosylation (CDGs), rare disorders caused by mutations that impair glycosylation—the complex process by which cells build long sugar chains that are attached to proteins called glycoproteins. D’Souza also works to uncover how these rare genetic mutations cause the observed symptoms.
Don Barach Memorial Fishman Fund Award
Huijie Huang, PhD, is a postdoctoral associate in the lab of Timothy Huang, PhD, an assistant professor in the Degenerative Diseases Program. Her research focuses on uncovering the fundamental causes of Alzheimer’s disease AD), a pressing public health concern as the U.S. population ages and faces an increased risk of this leading cause of dementia. Specifically, she studies the SORL1 (SORLA) gene, a known risk factor for sporadic early- and late-onset AD. Huang believes that developing treatments to boost SORLA’s beneficial effects may prove to be an innovative treatment approach.
Fishman Fund Fellowship Award
James Marchant, PhD, is a postdoctoral associate in the lab of Alexandre Colas, PhD, an associate professor in the Development, Aging and Regeneration Program. His research focuses on developing a gene therapy to treat heart failure. Heart attacks reduce blood and oxygen flow to heart muscle, leading to scar tissue that can increase the risk of future attacks. Marchant aims to convert cells within this scar tissue back into healthy muscle cells.
Cynthia Schwartz Shenkman Fishman Fund Research Excellence Award
Chiara Nicoletti, PhD, is a postdoctoral associate in the laboratory of Pier Lorenzo Puri, MD, co-director of the Development, Aging and Regeneration Program. She studies epigenetic patterns, which are genetic changes that don’t alter DNA itself yet modify how genes are expressed to make proteins or other products. She studies epigenetic patterns in skeletal muscle development and disease. Nicoletti hopes to help develop personalized medicine tools for patients suffering from muscular dystrophy.
Jeanne Jones and Kathryn Fishback Fishman Fund Award
Jessica Proulx, PhD, is a postdoctoral associate working in the lab of Peter D. Adams, PhD, director of the Cancer Genome and Epigenetics Program. Proulx investigates how aging alters our bodies at the cellular and molecular levels, a key factor in the increased risk for diseases such as cancer, neurodegenerative disorders, cardiovascular disease and metabolic conditions like type 2 diabetes. She uses biological techniques that study the entire landscape of a sample’s genes, proteins or other features. Her work seeks to identify underlying changes that predispose an aged liver to liver disease and liver cancer.
Lenka Finci and Erna Viterbi Fishman Fund Award
Kelly Yichen Li, PhD, is a postdoctoral associate in the lab of Kevin Yip, PhD, a professor in the Cancer Genome and Epigenetics Program and the director of the Bioinformatics Shared Resource. She studies a phenomenon called cellular senescence that is associated with aging. Senescent cells no longer grow and divide, which can reduce the growth of cancer, but the condition is also associated with chronic inflammation and age-related diseases. Yichen LI is working to find molecular signatures of senescence to advance aging research, treatments and diagnostics.
Institute News
Renovated auditorium and generous gift to strengthen community engagement at Sanford Burnham Prebys
A ribbon-cutting event on August 7 celebrated the philanthropic gift and state-of-the-art auditorium that will enable new community engagement events at the Institute.
Sanford Burnham Prebys unveiled its newly renovated auditorium in Building 12 during a special Happy Town Hall and ribbon-cutting ceremony on Wednesday, August 7, 2024. The improved meeting space was renamed as the Victor E. LaFave III Memorial Auditorium, or “the Vic,” in recognition of the generous support of the LaFave family.
Racheal McCabe, senior director of Philanthropy at Sanford Burnham Prebys, opened the festivities by welcoming members of the LaFave family, board members, faculty, staff and friends of the Institute. She provided details about the auditorium’s namesake, including his service in the U.S. Air Force and appreciation of sports, traveling, music, photography and gardening.
“Most of all, Vic showed a deep love for his beloved wife, Sue, and his family and friends,” said McCabe. “We included a hidden, golden turtle above the auditorium’s entrance as a special tribute to Sue’s love for the animal, and we think Vic would be pleased by that.”
“The tortoise and the turtle are universally seen as symbols of wisdom and knowledge, so it is quite fitting for representing the scientific discovery, education and learning that will take place in the Victor E. LaFave III Memorial Auditorium.”
McCabe introduced David A. Brenner, MD, president and CEO of Sanford Burnham Prebys, who said, “Thank you on behalf of the entire institute. This is going to be a transformational gift for our community engagement strategies and a pivotal place for collaboration and exchanging ideas.”
Brenner and Sue LaFave ceremonially cut a ribbon to formally announce the grand opening of the Vic. Guests entered the new auditorium to learn about the renovations and other updates at the institute.
Brenner discussed plans for the enhanced auditorium to be a prominent space for community engagement through new and ongoing events. The meeting space will help the institute connect with community members, alumni and research collaborators throughout the region and state.
A new community engagement program called “A Conversation About” will launch in the Vic on October 9, 2024. Taking inspiration from the Group of 12 educational discussions and the Insights streaming program, A Conversation About will feature expert panelists from the scientific and medical communities in dynamic discussions about the future of research and health care.
The A Conversation About series will focus on the four disease-focused, broadly collaborative research centers at Sanford Burnham Prebys: Cancer, Neurodegeneration and Aging, Metabolic and Liver, and Cardiovascular and Muscular.
By bringing together community collaborators and clinicians with Sanford Burnham Prebys researchers, A Conversation About will offer a unique perspective on how clinical research and practice can be used to inform fundamental and translational science.
Institute News
Hudson Freeze appointed to Distinguished Endowed Chair, thanks to gift from grateful supporter
An endowed chair is among the highest forms of recognition for a faculty member’s research, teaching and service.
Thanks to a generous gift from Dinah C. Ruch, Professor Hudson Freeze, PhD, director of the Sanford Children’s Health Research Center at Sanford Burnham Prebys, has received the William W. Ruch Distinguished Endowed Chair. The newly created chair will support Freeze’s research on congenital disorders of glycosylation (CDGs) and rare children’s diseases.
Freeze is a world-renowned expert on CDGs, a severe group of diseases that affect fewer than 2,000 children worldwide. He has been working on CDGs for more than 25 years and has worked with hundreds of patients from around the world. The condition occurs when sugar molecules on many of our proteins are absent or incomplete, leading to serious, often fatal, malfunctions in various organ systems throughout the body.
In 2007, Ruch established “The Rocket Fund” to support the heroic battle against heartbreaking rare and neglected children’s diseases. Ruch’s interest in CDG research was a result of her own family’s experience.
“My grandson John, whom we called ‘Rocket,’ was born with a CDG,” says Ruch. “Our doctors were able to quickly diagnose the disease, thanks to Dr. Freeze, who has now become a lifelong friend. Though we weren’t able to save Rocket, we are keeping his legacy alive by establishing this endowed chair to support Dr. Freeze and his commitment to finding a cure.”
Freeze’s impact on the lives of families living with CDG extends well beyond the walls of his lab. Since 2010, he has organized an annual Rare Disease Symposium, where scientists, doctors and families gather from around the world to discuss the latest research and meet other families coping with rare diseases.
“Patients are often diagnosed with rare genetic diseases at birth or in childhood, and families are usually overwhelmed by dealing with the diagnosis and complicated care regimens,” says Freeze. “I’m fortunate to have the opportunity to provide support to help these families through our work at the Sanford Children’s Health Research Center.
“I’m so very grateful to receive this honor from Dinah Ruch—and will continue my life’s work to provide education and resources so that people may live with the highest quality of life possible, and may one day, in fact, thrive.”
Sanford Burnham Prebys’ latest gala celebrated an old, dear friend, a brand-new vision and a crowd in fab form.
The event began with an evening filled with gratitude, recognition and, well, a look to the future.
On Saturday night, more than 280 friends, faculty and supporters of Sanford Burnham Prebys gathered at the Estancia La Jolla Hotel & Spa to celebrate the event’s theme: “A Future Filled with Discoveries and Cures.”
But more specifically, attendees paid homage to two men: philanthropist T. Denny Sanford, whose long and enduring support has helped shape and sustain Sanford Burnham Prebys; and David Brenner, MD, the institute’s (newish) president and CEO, who is using Sanford’s most recent gift to implement a bold, new strategic plan.
“Denny has always been a friend, guide and mentor,” said Brenner. “He has made much of what I do—what we will do together—possible.”
It was an evocative evening, with sartorially splendid guests arriving to a scene best described as a 1960s-era “lavish London lounge,” featuring vibrant colors and rich materials, roaming magicians; and a strolling trio of trumpet, trombone and tambourine players.
The festivities formally opened with welcoming remarks from Honorary Trustee Malin Burnham, who noted that “the Institute is at a dramatic time and place—with new faces, a new vision and an old friend.”
Burnham, who has served on the Board since 1982, noted that Sanford, who could not attend the event, was watching a live stream of the event from his home in South Dakota. “He can see and hear us,” Burnham said, waving.
Following dinner, Bill Gerhart, the current chair of the Sanford Burnham Prebys Board of Trustees, stepped up to acknowledge Sanford’s long history of support to the Institute and all of the donors, supporters and staff in the room who “make things happen”; and to introduce Brenner as “a guy who really can make things happen.”
Brenner, who also holds the Donald Bren Chief Executive Chair, spoke eloquently about Sanford before briefly detailing strategic plans for the Institute, one intended to put Sanford Burnham Prebys at the forefront of the current biomedical research revolution.
“Here’s my elevator speech,” Brenner said, inviting attendees to follow along by reading a program insert.
Our Mission
We translate science into health.
Biomedical research is undergoing a revolution, driven by big data, artificial intelligence and other emerging technologies.
We are uniquely positioned to lead because…
We study the toughest diseases: cancer, heart, mind and metabolic. We are forward-looking, unafraid of change or challenge. We are collaborative, flexible, multi-disciplinary and team-focused. We embrace data science. We promote entrepreneurship. We are central to a vibrant, local biomedical community.
A key part of the strategic plan, Brenner said, is embodied in the new cadre of young scientists recently recruited to Sanford Burnham Prebys from “some of the best labs at some of the best institutions in the country.”
Their recruitment (and new hires to follow) are the benefit of a $70 million gift from Sanford to create up to 20 new faculty positions in the next few years in diverse research areas including cancer, neurodegeneration and computational biology.
Four of the six new scientists were in attendance: Sanju Sinha, PhD, from the National Cancer Institute; Sanjeev Ranade, PhD, from Gladstone Institutes; Kelly Kersten, PhD, from UC San Francisco; and Xiao Tian, PhD, from Harvard Medical School.
Sinha joined the Institute in June. Kevin Tharp, PhD, from UCSF, arrives in November. The other four researchers, including Shengjie Feng, PhD, from the Howard Hughes Medical Institute and UCSF, officially join Sanford Burnham Prebys in January 2024.
Brenner then introduced a special four-minute video: a visual thank-you to Sanford and a visionary peek at the Institute’s next steps and aspirations. The video ended with a standing ovation.
With the lights still dim, the entertainment portion of the evening began: a live reimagining of John Lennon’s beloved 1971 song “Imagine,” dedicated to Sanford and the new strategic plan.
“Imagine there’s no illness It’s easy if we try…”
“You may say Denny’s a dreamer But he’s not the only one. We hope someday you’ll join us And the world can be as one.”
Then it was the Beatles’ tribute band “Abbey Road Show,“ a 70-minute set of music and narration chronicling the Fab Four, followed by nightcaps, conversation and thoughts about the next day—when the future begins.
Note: For your own free, handy, wallet-sized mission card or more information about how you can support Sanford Burnham Prebys, please contact the Philanthropy team.
Institute News
2023 Fishman Fund Award ceremony celebrates postdoctoral scholars
Three talented early-career researchers were presented with prestigious Fishman Fund Awards at the 22nd annual ceremony on September 20.
More than 100 generous benefactors, past award winners, and family and friends joined the celebration held at the Sanford Consortium.
Fishman Fund co-founder Reena Horowitz greeted the audience and shared how she, along with Mary Bradley, established the Fishman Fund Awards in 2001 to honor Dr. William and Lillian Fishman, founders of Sanford Burnham Prebys.
The Fishmans were committed to fostering the careers of young scientists. The award ceremony honors our founders’ dedication to furthering the careers of promising scientists by gathering each autumn to celebrate exceptional postdocs.
Before the awards were presented to the winners, David Brenner, MD, CEO of Sanford Burnham Prebys, described how important postdocs are to scientific discovery and why investing in their careers is a vital step toward improving human health.
“The postdoc experience is important, as it provides more training, experience and skills, before entering a more permanent science career,” said Brenner. “Postdocs represent the next generation of imagination and innovation, which much be recognized, encouraged and emboldened.”
Meet this year’s Fishman Fund Award winners
The Reena Horowitz & Mary Bradley Fishman Fund Founders Prize Cheng-Ju Kuo, PhD, a postdoctoral researcher in the lab of Dr. Caroline Kumsta, is studying the biology of aging. Dr. Kuo is unraveling the molecular mechanisms linked to a cellular recycling process that declines with age. His findings could open up new possibilities to treat age-released diseases. Dr. Kuo’s goal is to establish his own laboratory where he will study aging and train the next generation of scientists.
Jeanne Jones and Kathryn Fishback Fishman Fund Prize Alicia Llorente, PhD, a postdoctoral associate in the lab of Dr. Brooke Emerling, is investigating how breast cancer cells become resistant to therapy. Dr. Llorente combines her expertise in lipid kinases with cancer biology to open possibilities for novel therapeutics for therapy-resistant breast cancer. Her career goal is to combine research with teaching by obtaining a faculty position at a university.
Lenka Finci and Erna Viterbi Fishman Fund Prize Theo Tzaridis, MD, is a postdoctoral associate in the lab of Dr. Peter Adams, where he focuses on aggressive brain tumors. His research led to the identification of a key checkpoint molecule widely expressed in brain tumors, which is a significant step toward improving immunotherapy as a treatment for brain tumors. Dr. Tzaridis plans to become a leader in translating research findings into clinical trials.
Fishman Fund winners undergo a rigorous selection process that includes a personal interview and a presentation to the selection committee. All winners receive a $10,000 career development award that can be used to attend workshops, network and travel to national and international conferences to learn about the latest developments in their research fields.
A special thank-you to the Fishman Fund donors who make these awards possible.
Institute News
2022 Fishman Fund Awards honor postdoctoral researchers
Since 2001, the awards have paid tribute to our Institute’s heritage and supported the trailblazers of tomorrow
Last week, the Fishman Fund Awards were presented at the Sanford Consortium, marking the first in-person awards presentation for the scholarships since 2019. The Fishman Fund honors the legacy of the Institute’s founders, Dr. William and Mrs. Lillian Fishman, and its purpose is to support the next generation of scientific leaders.
“The Fishman Fund Awards are important to our community and to the future of science,” said President and CEO David Brenner, M.D., during his comments at the ceremony. “The Fishmans understood that supporting our young scientists is a critical investment in the future of research, and that postdocs are the lifeblood of a scientific enterprise and crucial to the process of discovery.”
Professor Hudson Freeze, PhD, the first Fishman Fund awardee, recalled how the award was given to faculty the first year, but after that became an award exclusively for postdoctoral researchers. “Those are the people who do the work, and without them, there is no Institute,” said Freeze.
Assistant Professor Caroline Kumsta, PhD, who was a Fishman Fund awardee in 2011, also spoke. “The Fishman Fund has shaped many aspects of my life, and I am honored to be one of the recipients,” she said.
The evening was emceed by Reena Horowitz, who established the Fishman Fund with the late Mary Bradley in 2001. Since then, 74 awards have been conferred. This year, three $10,000 awards were given to postdocs to support their career development. An additional fellowship that provides salary and benefits was also awarded.
“These awards are important because they provide the vital funds to young career scientists for professional development and collaborative opportunities,” Horowitz said. “It is these up-and-coming biomedical researchers who will make the medical discoveries of tomorrow, shape the future of healthcare and literally save lives.”
This year’s awards were presented to:
Guillem Lambies Barjau, PhD Jeanne Jones and Kathryn Fishback Fishman Fund Award
“I am honored to be here today. Thank you to Sanford Burnham Prebys and the Fishman Fund for giving me this opportunity.”
Lambies Barjau hopes to improve the outcome of patients with pancreatic cancer. In the lab of Cosimo Commisso, PhD, Lambies Barjau studies how pancreatic cancer cells gather nutrients from their environment to survive and grow. Pancreatic tumors exist in a harsh, nutrient-poor environment, but they can activate a process called macropinocytosis to scavenge molecules as an alternative source of energy. By deciphering this process, Lambies Barjau’s research may reveal novel approaches to slow the growth of these often-deadly tumors.
Shanshan Yin, PhD Lenka Finci and Erna Viterbi Fishman Fund Award
“I am grateful that you are our scientists’ strongest supporters. Together, we’ll do great science.”
Yin is studying the links between aging and breast cancer. About one in eight women will get breast cancer during her life, and the risk increases with age. In the lab of Peter Adams, PhD, Yin uses cutting-edge technology to quantify the activation of specific genes during aging. Identifying these genes may help explain why breast cancer occurs more frequently in older women, and could also lead to preventive treatments to spare the millions affected by the disease.
Tanja Eisemann, PhD Reena Horowitz and Mary Bradley Fishman Fund Award
“I can’t tell you how honored I am to receive a 2022 Fishman Fund Award. I would like to express my deepest gratitude to the Fishman Fund donors for their generosity.”
Eisemann is exploring approaches to leverage the immune system against medulloblastoma, one of the most aggressive childhood brain cancers. Although rare, there are still about 500 children in the U.S. diagnosed each year with this dangerous cancer. In the lab of Robert Wechsler-Reya, PhD, Eisemann studies the interactions between T cells and medulloblastoma tumor cells, opening new research avenues to discover therapies that can enhance a patient’s own immune system to slow—or even eliminate—this dangerous brain cancer.
Cynthia Lebeaupin, PhD Fishman Fund Fellowship
“The Fishman Fund Fellowship and the resources at Sanford Burnham Prebys will ensure I canperform science of excellent quality and make a lasting impact. Thank you for your support.”
Lebeaupin works in the laboratory of Randal J. Kaufman, PhD, where she studies how fatty liver disease leads to liver cancer. Fatty liver disease, which affects more than 25% of the U.S. population, develops when the body creates too much fat or can’t metabolize fat efficiently enough. There are no treatments or cures for this chronic liver condition and no methods of early detection. Lebeaupin’s research aims to address this unmet medical need by uncovering the biological pathways that lead to liver cancer and translating these findings into effective therapies.
Institute News
2021 Fishman Fund Award ceremony celebrates postdoctoral scholars
The Fishman Fund Awards were presented on September 23, 2021, in a virtual ceremony that honored the enduring legacy of our Institute’s founders, Dr. William and Lillian Fishman.
The three exceptional winners were welcomed by Fishman Fund co-founder Reena Horowitz; co-founder designee Jeanne Jones; and 2018 award recipient Laura Martin-Sancho, who commented, “A Fishman Fund Award is more than the money—it means that someone believes in you and believes in your goals.”
Longtime supporter, Institute trustee and namesake Malin Burnham reflected on his first meeting with the Fishmans more than 40 years ago when they were setting the stage for Sanford Burnham Prebys. “The Fishmans were creating a collaborative, inspirational atmosphere for postdocs—the lifeblood of scientific enterprise. This award pays tribute to their vision that young, talented scientists hold the key to curing disease.”
Sanford Burnham Prebys CEO Randy C. Mills thanked our supporters and shared, “Fishman Fund Award winners are on a journey not only to make their mark through scientific discovery, but also to define themselves as scientific leaders. I’m excited to see the vision of better science that they will translate into reality for the benefit of patients in need.”
Reena Horowitz and the late Mary Bradley established the Fishman Fund Awards in 2001 to honor the Fishmans and advance the careers of promising young scientists. Ever since the fund was launched 20 years ago, more than 70 awards have been conferred—now worth $10,000—to support career-development activities.
This year’s awards were presented to:
Cynthia Lebeaupin, PhD The Lenka Finca and Erna Viterbi Fishman Fund Prize
“I’m especially grateful to be affiliated with a community that supports its postdoctoral researchers, helping us transition into the great leaders of tomorrow.”
Dr. Lebeaupin is studying how fatty liver disease progresses to liver cancer. Fatty liver disease is rapidly increasing in the U.S. and around the world—and there is no cure. Studying how cells respond to stress conditions may open new avenues to target those responses and prevent cancer. Dr. Lebeaupin, a postdoctoral associate in the lab of Randal J. Kaufman, PhD, aims to become a professor of biology in academia.
Valeria Guglielmi, PhD The Reena Horowitz and Mary Bradley Fishman Fund Founders Award
“Now more than ever, we need people like you who trust scientists and believe science can really make a difference in our lives.”
Dr. Guglielmi is researching nuclear pore complexes and their role in the development and activity of immune cells. This research may lead to novel treatments for health conditions caused by dysregulated immune-cell production and function. Guglielmi is a postdoctoral associate in the lab of Maximiliano D’Angelo, PhD, and her goal is to become an independent investigator to further research on the immune system.
Paulina Sosicka, PhD The Jeanne Jones and Kathryn Fishback Fishman Fund Prize
“I’m very grateful and honored to receive this Fishman Fund Career Development Award. Thank you to the founders and donors who made this possible.”
Dr. Sosicka is investigating the application of dietary supplementation to treat debilitating genetic conditions called CDGs, which are rare diseases—mainly affecting children—caused by defects in the human enzymes and proteins responsible for adding sugar molecules onto proteins and lipids. The research may also provide insights into new approaches to treat obesity and cancer. A postdoctoral associate in the lab of Hudson Freeze, PhD, Dr. Sosicka aspires to become a professor in academia in the field of glycobiology.
Event recording
Institute News
Celebrating the next generation of biomedical trailblazers at the 19th annual Fishman Fund Awards
Four talented early-career researchers were awarded prestigious Fishman Fund Awards.
When Dr. William and Lillian Fishman founded our Institute in 1976, they knew that nurturing the next generation of scientists was just as important as advancing cutting-edge research. Today, their values live on in the form of the Fishman Fund Awards, which help exceptional postdoctoral researchers develop into scientific leaders.
On September 24, four talented early-career researchers received the prestigious award during an inspiring virtual ceremony. Generous benefactors, past award winners, and family and friends tuned into the event, which featured remarks from Institute president Kristiina Vuori, MD, PhD; professor and Fishman Fund Award recipient José Luis Millán, PhD; Fishman Fund co-founder Reena Horowitz and co-founder designee Jeanne Jones.
“The Fishmans firmly believed in helping brilliant early-career postdoctoral scientists become great principal investigators,” says Ms. Horowitz, who established the Fishman Fund Awards in 2001 with her late friend Mary Bradley. “Our goal with these awards is to encourage and support these researchers in their quest for the next great medical breakthroughs, which might one day be able to save the lives of our family members, friends and neighbors.”
Fishman Fund winners undergo a rigorous selection process that includes a personal interview and a presentation to the selection committee. All winners receive a $10,000 career development award that can be used to attend workshops, network and travel to national and international conferences to learn about the latest developments in their research fields. The winner of the Fishman Fund Fellowship receives a two-year salary stipend in addition to the professional development funding.
Meet this year’s Fishman Fund Award winners
Fishman Fund Fellowship Award
Kyungsoo Shin, PhD, grew up in Halifax, Nova Scotia, in Canada, where he also attended Dalhousie University for his undergraduate and graduate studies. Dr. Shin works in the laboratory of Dr. Francesca Marassi, where he is advancing a potential treatment for age-related macular degeneration, a leading cause of vision loss in people over the age of 60. Dr. Shin recently showed that a protein called vitronectin is the likely cause of the pebble-like deposits in the back of the eye that underlie the disease. With this information, scientists can now work toward a treatment to prevent vision loss.
Dr. Shin’s career goal is to become an independent researcher focused on understanding how cellular membranes—gatekeepers that regulate what enters or exits a cell—are involved in disease. He hopes to mentor and inspire the next generation of scientists to advance our understanding of human biology.
Fishman Fund Career Development Awards
Marie Berenguer, PhD, grew up near Paris and went to school in Bordeaux. She is currently studying in the laboratory of Dr. Gregg Duester and focuses on how a compound called retinoic acid affects the way embryos are formed. Her work may open new avenues to prevent and treat birth defects.
Dr. Berenguer’s career goal is to become a principal investigator and lecturer in genetics and developmental biology. By leading her own research team, she hopes to improve our understanding of genetic diseases and lay the foundation for future therapies.
Daniela Dengler, PhD, is from Germany, where she studied pharmacy and worked in a pharmacy for a year before she decided to pursue her PhD at the Friedrich-Alexander University in Erlangen-Nuremberg, Germany. Dr. Dengler works in the Conrad Prebys Center for Chemical Genomics with Dr. Eduard Sergienko. She is searching for new drugs that bind to proteins called G-protein coupled receptors (GPCRs), which mediate many physiological processes in the body. More than 30% of all FDA-approved drugs act on GPCRs.
Dr. Dengler’s career goal is to become a project leader in biotech, where she wants to combine her background in chemistry with her knowledge in assay development and high-throughput screening to find drugs for unmet medical needs.
Chiara Nicoletti, PhD, grew up in Gela, in Sicily, and received her PhD at the University of Padua in northern Italy. Dr. Nicletti is in Dr. Pier Lorenzo Puri’s lab and is studying the links between genetic sequences and risk of disease. Her research will open new avenues to help clinicians practice personalized medicine—including predicting who is likely to get a disease, how to prevent it, how to treat it and perhaps even cure the condition.
Dr. Nicoletti’s career goal is to become a principal investigator, leading her own research team that focuses on integrating foundational research with everyday medical practice to improve human health.
Watch the Fishman Fund Awards ceremony, which featured remarks from Institute president Kristiina Vuori, MD, PhD; professor and Fishman Fund Award recipient José Luis Millán, PhD; Fishman Fund co-founder Reena Horowitz and co-founder designee Jeanne Jones.
Learn more about the Fishman Fund, or, donate now, to support future scientific leaders.